002550 千紅製藥
按盤價 
5.620 -0.030 (-0.531%)
5.620 -0.030 (-0.531%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.614 | 7.415 | 14.130 | 8.608 | -5.980 |
| 總資產報酬率 ROA (%) | 6.775 | 6.528 | 12.171 | 7.301 | -4.902 |
| 投入資產回報率 ROIC (%) | 7.463 | 7.138 | 13.454 | 8.285 | -6.079 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.698 | 43.265 | 38.591 | 44.462 | 47.613 |
| 營業利潤率 (%) | 23.908 | 11.264 | 15.628 | 11.165 | -9.880 |
| 息稅前利潤/營業總收入 (%) | 23.456 | 10.866 | 12.422 | 11.465 | -8.894 |
| 淨利潤/營業總收入 (%) | 20.620 | 9.848 | 13.888 | 9.939 | -8.853 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 98.015 | 72.829 | 86.680 | 70.290 | -116.592 |
| 價值變動淨收益/利潤總額(%) | 0.685 | 4.312 | -1.273 | 0.306 | -9.480 |
| 營業外收支淨額/利潤總額(%) | 0.432 | -0.409 | 0.090 | 0.019 | 2.578 | 償債能力分析 |
| 流動比率 (X) | 8.430 | 7.900 | 6.065 | 5.298 | 5.351 |
| 速動比率 (X) | 5.855 | 4.975 | 4.136 | 3.946 | 4.265 |
| 資產負債率 (%) | 10.320 | 10.563 | 13.276 | 15.557 | 15.758 |
| 帶息債務/全部投入資本 (%) | -2.812 | -0.654 | 1.024 | 0.704 | -- |
| 股東權益/帶息債務 (%) | -3,514.171 | -14,863.128 | 9,308.957 | 13,501.109 | -5,052.999 |
| 股東權益/負債合計 (%) | 864.383 | 840.232 | 657.760 | 545.117 | 538.367 |
| 利息保障倍數 (X) | -42.220 | -30.840 | -3.857 | 38.525 | -7.131 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 55.857 | 78.390 | 75.078 | 75.332 | 0.000 |
| 存貨周轉天數 (天) | 235.289 | 199.089 | 119.244 | 123.871 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/08/2024 13:53 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
